“Pioneers in neuroscience”? Give me a break. Biogen seems more a financial than a scientific organization. Not a suitable partner or merger prospect, IMO. We are better than that. Seeking to bring medicine to market that will actually help patients suffering from CNS diseases is our mission first and foremost not just to feed our bottom line. Along the way, we may even find a cure for a disease or two; Biogen, not a chance.
News 
Market Data 
Discover 
